$2.76 Billion is the total value of Rock Springs Capital Management LP's 144 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | Buy | UNITEDHEALTH GROUP INC | $156,724,000 | +12.6% | 589,098 | +3.8% | 5.67% | +5.9% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $81,164,000 | +19.5% | 141,400 | -0.4% | 2.94% | +12.5% |
| MOH | MOLINA HEALTHCARE INC | $81,042,000 | +51.8% | 545,000 | 0.0% | 2.93% | +42.8% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $79,303,000 | +28.1% | 645,000 | +2.3% | 2.87% | +20.5% |
| WCG | Buy | WELLCARE HEALTH PLANS INC | $75,475,000 | +37.4% | 235,500 | +5.6% | 2.73% | +29.3% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $73,232,000 | -23.5% | 342,000 | -0.1% | 2.65% | -28.0% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $70,368,000 | +469.3% | 4,325,000 | +8.1% | 2.55% | +435.3% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $69,096,000 | +12.5% | 400,000 | -9.1% | 2.50% | +5.9% |
| PCRX | Buy | PACIRA PHARMACEUTICALS INC | $63,525,000 | +65.4% | 1,292,479 | +7.9% | 2.30% | +55.7% |
| HCA | Buy | HCA HEALTHCARE INC | $63,300,000 | +43.5% | 455,000 | +5.8% | 2.29% | +35.0% |
| EHC | Buy | ENCOMPASS HEALTH CORP | $52,733,000 | +73.0% | 676,500 | +50.3% | 1.91% | +62.7% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $50,149,000 | +27.5% | 310,500 | +4.4% | 1.82% | +20.0% |
| IRTC | IRHYTHM TECHNOLOGIES INC | $45,437,000 | +16.7% | 480,000 | 0.0% | 1.64% | +9.8% | |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $41,703,000 | -31.8% | 300,000 | -39.1% | 1.51% | -35.8% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $37,777,000 | +16.7% | 196,000 | +2.9% | 1.37% | +9.8% |
| BGNE | BEIGENE LTDsponsored adr | $37,027,000 | +12.0% | 215,000 | 0.0% | 1.34% | +5.4% | |
| PEN | Sell | PENUMBRA INC | $35,209,000 | +7.6% | 235,200 | -0.7% | 1.28% | +1.3% |
| LOXO | Sell | LOXO ONCOLOGY INC | $34,675,000 | -31.1% | 202,981 | -30.0% | 1.26% | -35.1% |
| TFX | Buy | TELEFLEX INC | $32,995,000 | +33.0% | 124,000 | +34.1% | 1.20% | +25.1% |
| CELG | CELGENE CORP | $32,252,000 | +12.7% | 360,400 | 0.0% | 1.17% | +6.1% | |
| SYK | Buy | STRYKER CORP | $31,805,000 | +5.8% | 179,000 | +0.6% | 1.15% | -0.4% |
| PRAH | PRA HEALTH SCIENCES INC | $31,762,000 | +18.0% | 288,247 | 0.0% | 1.15% | +11.0% | |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $31,338,000 | +30.5% | 180,000 | +9.1% | 1.14% | +22.8% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $30,800,000 | +446.0% | 800,000 | +363.8% | 1.12% | +413.8% |
| INGN | Buy | INOGEN INC | $30,759,000 | +38.7% | 126,000 | +5.9% | 1.11% | +30.6% |
| ABBV | Sell | ABBVIE INC | $30,739,000 | -44.7% | 325,000 | -45.8% | 1.11% | -48.0% |
| EXAS | Buy | EXACT SCIENCES CORP | $30,384,000 | +33.7% | 385,000 | +1.3% | 1.10% | +25.9% |
| ZBH | Buy | ZIMMER BIOMET HLDGS INC | $29,581,000 | +64.9% | 225,000 | +39.8% | 1.07% | +55.2% |
| ONCE | Sell | SPARK THERAPEUTICS INC | $29,321,000 | -34.9% | 537,500 | -1.2% | 1.06% | -38.7% |
| DVA | DAVITA INC | $29,261,000 | +3.2% | 408,500 | 0.0% | 1.06% | -3.0% | |
| WMGI | WRIGHT MED GROUP N V | $29,020,000 | +11.8% | 1,000,000 | 0.0% | 1.05% | +5.2% | |
| TSRO | Buy | TESARO INC | $28,672,000 | +3.1% | 735,000 | +17.5% | 1.04% | -3.0% |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $27,181,000 | +9.9% | 1,632,500 | +4.3% | 0.98% | +3.5% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $26,407,000 | +16.9% | 67,500 | +2.3% | 0.96% | +10.0% |
| ACHC | Sell | ACADIA HEALTHCARE COMPANY IN | $24,640,000 | -52.0% | 700,000 | -44.2% | 0.89% | -54.8% |
| INCY | Buy | INCYTE CORP | $24,323,000 | +22.6% | 352,100 | +19.0% | 0.88% | +15.5% |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $24,322,000 | -38.2% | 1,650,100 | +0.0% | 0.88% | -41.8% |
| TMO | THERMO FISHER SCIENTIFIC INC | $23,432,000 | +17.8% | 96,000 | 0.0% | 0.85% | +10.8% | |
| NVTA | INVITAE CORP | $23,422,000 | +127.6% | 1,400,000 | 0.0% | 0.85% | +114.1% | |
| BAX | BAXTER INTL INC | $22,896,000 | +4.4% | 297,000 | 0.0% | 0.83% | -1.8% | |
| RDUS | Buy | RADIUS HEALTH INC | $22,562,000 | -31.9% | 1,267,500 | +12.7% | 0.82% | -36.0% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $22,356,000 | -20.6% | 487,600 | +2.5% | 0.81% | -25.3% |
| IDXX | Buy | IDEXX LABS INC | $20,847,000 | +32.9% | 83,500 | +16.0% | 0.76% | +25.0% |
| MDCO | MEDICINES CO | $20,638,000 | -18.5% | 690,000 | 0.0% | 0.75% | -23.3% | |
| OBSV | OBSEVA SA | $20,194,000 | +19.1% | 1,120,000 | 0.0% | 0.73% | +11.9% | |
| AXGN | Sell | AXOGEN INC | $20,027,000 | -26.9% | 543,474 | -0.3% | 0.72% | -31.2% |
| GLPG | Sell | GALAPAGOS NVspon adr | $19,956,000 | +17.0% | 177,500 | -4.1% | 0.72% | +10.2% |
| WST | WEST PHARMACEUTICAL SVSC INC | $19,755,000 | +24.4% | 160,000 | 0.0% | 0.72% | +17.0% | |
| FGEN | Sell | FIBROGEN INC | $18,590,000 | -3.3% | 306,000 | -0.3% | 0.67% | -9.1% |
| ALLK | New | ALLAKOS INC | $18,221,000 | – | 405,000 | +100.0% | 0.66% | – |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $18,199,000 | +3.1% | 490,000 | +8.9% | 0.66% | -2.9% |
| INSM | Buy | INSMED INC | $17,996,000 | -7.8% | 890,000 | +7.9% | 0.65% | -13.2% |
| TBPH | Sell | THERAVANCE BIOPHARMA INC | $17,969,000 | +21.4% | 550,000 | -15.7% | 0.65% | +14.2% |
| BIIB | Sell | BIOGEN INC | $17,666,000 | +14.8% | 50,000 | -5.7% | 0.64% | +8.1% |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $17,254,000 | +6.5% | 243,500 | 0.0% | 0.62% | +0.3% | |
| ARNA | ARENA PHARMACEUTICALS INC | $17,258,000 | +5.6% | 375,000 | 0.0% | 0.62% | -0.6% | |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $17,198,000 | +0.6% | 196,500 | +13.3% | 0.62% | -5.3% |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $16,827,000 | +0.1% | 425,025 | -3.4% | 0.61% | -5.9% |
| HRTX | HERON THERAPEUTICS INC | $16,616,000 | -18.5% | 525,000 | 0.0% | 0.60% | -23.3% | |
| ANAB | Buy | ANAPTYSBIO INC | $16,462,000 | +54.5% | 165,000 | +10.0% | 0.60% | +45.4% |
| IMMU | Buy | IMMUNOMEDICS INC | $16,143,000 | +36.4% | 775,000 | +55.0% | 0.58% | +28.4% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $15,612,000 | +23.6% | 200,000 | +0.5% | 0.56% | +16.3% |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $15,268,000 | -0.7% | 200,000 | 0.0% | 0.55% | -6.6% | |
| ECYT | Buy | ENDOCYTE INC | $15,096,000 | +62.1% | 850,000 | +25.9% | 0.55% | +52.8% |
| RARX | RA PHARMACEUTICALS INC | $13,568,000 | +81.8% | 750,000 | 0.0% | 0.49% | +71.1% | |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $13,241,000 | +18.4% | 4,125,000 | +4.4% | 0.48% | +11.4% |
| XENT | Buy | INTERSECT ENT INC | $13,225,000 | -13.9% | 460,000 | +12.2% | 0.48% | -19.0% |
| EPZM | EPIZYME INC | $13,157,000 | -21.8% | 1,241,253 | 0.0% | 0.48% | -26.4% | |
| ELAN | New | ELANCO ANIMAL HEALTH INC | $13,084,000 | – | 375,000 | +100.0% | 0.47% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $12,778,000 | -25.2% | 880,000 | +2.8% | 0.46% | -29.6% |
| ARGX | Buy | ARGENX SEsponsored adr | $12,514,000 | +17.3% | 165,000 | +28.2% | 0.45% | +10.2% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $12,493,000 | +35.0% | 475,000 | +5.0% | 0.45% | +27.0% |
| GTHX | Sell | G1 THERAPEUTICS INC | $12,187,000 | -6.5% | 233,073 | -22.3% | 0.44% | -12.2% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $12,121,000 | +2.9% | 125,000 | 0.0% | 0.44% | -3.1% | |
| FOLD | AMICUS THERAPEUTICS INC | $12,090,000 | -22.6% | 1,000,000 | 0.0% | 0.44% | -27.1% | |
| ZGNX | Buy | ZOGENIX INC | $11,656,000 | +16.7% | 235,000 | +4.0% | 0.42% | +9.9% |
| A | Buy | AGILENT TECHNOLOGIES INC | $11,576,000 | +14.4% | 164,100 | +0.2% | 0.42% | +7.4% |
| RTRX | RETROPHIN INC | $11,492,000 | +5.4% | 400,000 | 0.0% | 0.42% | -1.0% | |
| MRTX | MIRATI THERAPEUTICS INC | $11,304,000 | -4.5% | 240,000 | 0.0% | 0.41% | -10.1% | |
| CHRS | Sell | COHERUS BIOSCIENCES INC | $11,055,000 | +14.4% | 670,000 | -2.9% | 0.40% | +7.5% |
| ARDX | ARDELYX INC | $10,986,000 | +17.6% | 2,525,557 | 0.0% | 0.40% | +10.6% | |
| FIXX | HOMOLOGY MEDICINES INC | $10,744,000 | +12.1% | 470,000 | 0.0% | 0.39% | +5.4% | |
| EXEL | EXELIXIS INC | $10,543,000 | -17.7% | 595,000 | 0.0% | 0.38% | -22.5% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $10,170,000 | +14.2% | 750,000 | 0.0% | 0.37% | +7.3% | |
| TBIO | Sell | TRANSLATE BIO INC | $10,092,000 | -21.1% | 1,009,179 | -0.2% | 0.36% | -25.8% |
| MRSN | MERSANA THERAPEUTICS INC | $10,000,000 | -44.0% | 1,000,000 | 0.0% | 0.36% | -47.3% | |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $9,763,000 | -37.9% | 260,000 | -34.6% | 0.35% | -41.6% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $9,226,000 | +36.7% | 347,500 | +17.8% | 0.33% | +28.5% |
| ACHN | Buy | ACHILLION PHARMACEUTICALS IN | $8,832,000 | +32.8% | 2,400,000 | +2.1% | 0.32% | +25.0% |
| APTX | Sell | APTINYX INC | $8,833,000 | +7.5% | 305,000 | -10.3% | 0.32% | +1.3% |
| RTIX | RTI SURGICAL INC | $8,775,000 | -2.2% | 1,950,000 | 0.0% | 0.32% | -7.8% | |
| PTLA | PORTOLA PHARMACEUTICALS INC | $8,623,000 | -29.5% | 323,800 | 0.0% | 0.31% | -33.8% | |
| ODT | Buy | ODONATE THERAPEUTICS INC | $8,453,000 | -3.7% | 435,500 | +9.5% | 0.31% | -9.5% |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $8,324,000 | -11.2% | 598,000 | +0.8% | 0.30% | -16.6% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $7,962,000 | -31.3% | 271,100 | +6.3% | 0.29% | -35.4% |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $7,905,000 | – | 92,500 | +100.0% | 0.29% | – |
| BLUE | Buy | BLUEBIRD BIO INC | $7,665,000 | +8.5% | 52,500 | +16.7% | 0.28% | +2.2% |
| KURA | Buy | KURA ONCOLOGY INC | $7,088,000 | -2.6% | 405,000 | +1.2% | 0.26% | -8.2% |
| SAGE | SAGE THERAPEUTICS INC | $6,921,000 | -9.8% | 49,000 | 0.0% | 0.25% | -14.9% | |
| ZLAB | Buy | ZAI LAB LTDadr | $6,818,000 | -2.3% | 350,000 | +16.7% | 0.25% | -7.8% |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $6,799,000 | -12.7% | 613,604 | +5.8% | 0.25% | -18.0% |
| DERM | DERMIRA INC | $6,540,000 | +18.5% | 600,000 | 0.0% | 0.24% | +11.8% | |
| CO | Buy | GLOBAL CORD BLOOD CORPORATIO | $6,466,000 | -22.6% | 925,000 | +5.1% | 0.23% | -27.1% |
| RYTM | RHYTHM PHARMACEUTICALS INC | $6,272,000 | -6.7% | 215,000 | 0.0% | 0.23% | -12.4% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $6,221,000 | -9.5% | 650,000 | 0.0% | 0.22% | -15.1% | |
| IFRX | New | INFLARX NV | $6,092,000 | – | 177,500 | +100.0% | 0.22% | – |
| NVAX | NOVAVAX INC | $6,110,000 | +40.3% | 3,250,000 | 0.0% | 0.22% | +31.5% | |
| TORC | Buy | RESTORBIO INC | $6,056,000 | +140.7% | 400,000 | +45.5% | 0.22% | +125.8% |
| CLSD | CLEARSIDE BIOMEDICAL INC | $5,996,000 | -42.5% | 975,000 | 0.0% | 0.22% | -45.9% | |
| MGNX | MACROGENICS INC | $5,896,000 | +3.8% | 275,000 | 0.0% | 0.21% | -2.7% | |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $5,700,000 | -15.9% | 150,000 | 0.0% | 0.21% | -21.1% | |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $5,673,000 | -12.5% | 281,800 | +26.8% | 0.20% | -18.0% |
| SPRO | SPERO THERAPEUTICS INC | $5,518,000 | -28.4% | 525,000 | 0.0% | 0.20% | -32.4% | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $5,445,000 | +14.2% | 900,000 | 0.0% | 0.20% | +7.1% | |
| ALDER BIOPHARMACEUTICALS INCnote 2.500% 2/0 | $5,362,000 | +3.0% | 5,000,000 | 0.0% | 0.19% | -3.0% | ||
| BCRX | Buy | BIOCRYST PHARMACEUTICALS | $5,341,000 | +272.7% | 700,000 | +180.0% | 0.19% | +250.9% |
| INSMED INCnote 1.750% 1/1 | $5,073,000 | -8.3% | 6,000,000 | 0.0% | 0.18% | -13.6% | ||
| CRVS | CORVUS PHARMACEUTICALS INC | $4,934,000 | -21.9% | 575,000 | 0.0% | 0.18% | -26.3% | |
| Buy | NABRIVA THERAPEUTICS PLC | $4,860,000 | +118.2% | 1,800,000 | +181.2% | 0.18% | +104.7% | |
| CORV | CORREVIO PHARMA CORP | $4,824,000 | +6.3% | 1,200,000 | 0.0% | 0.18% | 0.0% | |
| MEDICINES COnote 2.750% 7/1 | $4,560,000 | -9.7% | 5,000,000 | 0.0% | 0.16% | -14.9% | ||
| SLDB | SOLID BIOSCIENCES INC | $4,482,000 | +32.4% | 95,000 | 0.0% | 0.16% | +24.6% | |
| PRTK | PARATEK PHARMACEUTICALS INC | $4,365,000 | -4.9% | 450,000 | 0.0% | 0.16% | -10.7% | |
| CGEN | COMPUGEN LTDord | $4,151,000 | +16.7% | 1,078,165 | 0.0% | 0.15% | +9.5% | |
| ITCI | INTRA CELLULAR THERAPIES INC | $4,069,000 | +22.8% | 187,500 | 0.0% | 0.15% | +15.7% | |
| CMTA | CLEMENTIA PHARMACEUTICALS IN | $3,847,000 | -15.3% | 345,000 | 0.0% | 0.14% | -20.6% | |
| VKTX | New | VIKING THERAPEUTICS INC | $3,484,000 | – | 200,000 | +100.0% | 0.13% | – |
| AGN | ALLERGAN PLC | $3,365,000 | +14.3% | 17,665 | 0.0% | 0.12% | +8.0% | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $3,323,000 | -18.7% | 268,000 | 0.0% | 0.12% | -23.6% | |
| MNLO | MENLO THERAPEUTICS INC | $3,251,000 | +21.3% | 330,000 | 0.0% | 0.12% | +14.6% | |
| MEDICINES COnote 2.500% 1/1 | $3,231,000 | -11.7% | 3,000,000 | 0.0% | 0.12% | -17.0% | ||
| ARVN | New | ARVINAS INC | $2,531,000 | – | 150,000 | +100.0% | 0.09% | – |
| CHMA | CHIASMA INC | $1,890,000 | +139.8% | 525,000 | 0.0% | 0.07% | +126.7% | |
| THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $1,770,000 | +18.7% | 1,500,000 | 0.0% | 0.06% | +12.3% | ||
| NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,707,000 | +18.0% | 1,000,000 | 0.0% | 0.06% | +10.7% | ||
| MCRB | SERES THERAPEUTICS INC | $1,670,000 | -11.7% | 220,000 | 0.0% | 0.06% | -17.8% | |
| CDTX | CIDARA THERAPEUTICS INC | $1,320,000 | -15.4% | 300,000 | 0.0% | 0.05% | -20.0% | |
| NVCR | New | NOVOCURE LTD | $1,310,000 | – | 25,000 | +100.0% | 0.05% | – |
| UROV | New | UROVANT SCIENCES LTD | $1,200,000 | – | 100,000 | +100.0% | 0.04% | – |
| RADIUS HEALTH INCnote 3.000% 9/0 | $1,153,000 | -17.6% | 1,500,000 | 0.0% | 0.04% | -22.2% | ||
| PACIRA PHARMACEUTICALS INCnote 2.375% 4/0 | $1,060,000 | +13.7% | 1,000,000 | 0.0% | 0.04% | +5.6% | ||
| SCYX | SCYNEXIS INC | $984,000 | -26.8% | 820,000 | 0.0% | 0.04% | -30.8% | |
| DERMIRA INCnote 3.000% 5/1 | $834,000 | +0.8% | 1,000,000 | 0.0% | 0.03% | -6.2% | ||
| GTXI | New | GTX INC DELcall | $79,000 | – | 50,000 | +100.0% | 0.00% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -5,000 | -100.0% | -0.03% | – |
| PRTA | Exit | PROTHENA CORP PLCcall | $0 | – | -85,000 | -100.0% | -0.05% | – |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS IN | $0 | – | -471,321 | -100.0% | -0.05% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -90,000 | -100.0% | -0.06% | – |
| Exit | EGALET CORPnote 5.500% 4/0 | $0 | – | -7,800,000 | -100.0% | -0.11% | – | |
| EVHC | Exit | ENVISION HEALTHCARE CORP | $0 | – | -110,300 | -100.0% | -0.19% | – |
| GTXI | Exit | GTX INC DEL | $0 | – | -354,000 | -100.0% | -0.21% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -400,000 | -100.0% | -0.61% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -98,000 | -100.0% | -0.65% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -220,000 | -100.0% | -0.72% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -372,500 | -100.0% | -0.75% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -365,000 | -100.0% | -1.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-05-01 |
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.